Pharma

Healix's Jeffrey Erb on what pharma giants consolidating accounts means for agencies

Healix's Jeffrey Erb on what pharma giants consolidating accounts means for agencies

By

Bigger budgets, fewer accounts. That's the dilemma facing pharma marketers as drugmakers consolidate work.

Interview | John Strapp, The Kinetix Group

Interview | John Strapp, The Kinetix Group

By

Key account managers for pharma brands can call on a major healthcare system and simultaneously change behavior in 1,000 HCPs. So it's really a B2B sell, explains The Kinetix Group's John Strapp.

Focus turns to future after Right to Try Act passes

Focus turns to future after Right to Try Act passes

Congress has finally passed the Right to Try Act, but does it go far enough?

'Long way to go' before top pharma companies' digital presence measures up to current tech standards: study

'Long way to go' before top pharma companies' digital presence measures up to current tech standards: study

A cross section of pharma brand websites fell short across all measured areas, including consumer experience, technology, SEO, and analytics, researchers said.

GSK digital leader brings tech flair

GSK digital leader brings tech flair

By

GSK consumer healthcare chief digital officer Marc Speichert talks about being a builder.

What pharma brands can learn from Amazon's inaugural Voice Summit

What pharma brands can learn from Amazon's inaugural Voice Summit

As the "age of touch," as Amazon calls it, gradually gives way to voice, it's even more important to have a robust search strategy.

Acquisition fever in July: What does it mean for agencies?

Acquisition fever in July: What does it mean for agencies?

By

Health agencies are in acquisition mode, with networks snapping up independents, and the M&A market looks poised to stay hot.

Pfizer reorg came on heels of its walk-back on price hikes

Pfizer reorg came on heels of its walk-back on price hikes

Wednesday's reorg was designed to position the company for growth in the face of the imminent patent cliff for megablockbuster Lyrica.

Live, from Cannes: Interview | Angela Radcliffe, PulsePoint & Mark Evans, Langland

Live, from Cannes: Interview | Angela Radcliffe, PulsePoint & Mark Evans, Langland

How can consumer marketing behavior be integrated into the clinical trial space? At Cannes, Angela Radcliffe, GM of clinical trial solutions at PulsePoint, and Mark Evans, innovation director at Langland, discuss why it's imperative to change how clinical trials are marketed.

How the Amazon-PillPack deal could benefit pharma and win over patients

How the Amazon-PillPack deal could benefit pharma and win over patients

By

A survey from DRG Digital measured patient and doctor support for Amazon becoming an online pharmacy.

Inside pharma's trust problem

Inside pharma's trust problem

By

Public trust in the pharma industry has taken a dip, according to recent data. Do actual patients agree?

Fostering a diverse, inclusive work environment for LGBTQ talent

Fostering a diverse, inclusive work environment for LGBTQ talent

According to a 2014 study conducted by The Human Rights Campaign, the largest LGBTQ civil rights advocacy group in the U.S., 53% of all LGBTQ workers nationwide "hide who they are in the workplace."

Lions Health: 2018 pharma winners

Lions Health: 2018 pharma winners

Here are the Lions Health winners in the pharma category.

No pharma Grand Prix awarded for second straight year

No pharma Grand Prix awarded for second straight year

By

Since the inception of the award in 2014, the pharma Grand Prix has only been awarded twice.

Confusion expected in wake of 'Right to Try' bill's signing

Confusion expected in wake of 'Right to Try' bill's signing

It's still entirely up to drugmakers whether they want to make their products available on an experimental basis. Patients may not see it that way.

Is it time for pharma ad agencies to reboot?

Is it time for pharma ad agencies to reboot?

As global advertisers cut their spending, should the agency world take a hard look in the mirror?

We asked for your take on pharma's diversity push. Here are the responses

We asked for your take on pharma's diversity push. Here are the responses

MM&M asked the pharma marketing community at large, via social media and other efforts, to provide its POV on equality, diversity, and inclusion.

Five things for pharma marketers to know: Monday, June 4, 2018

Five things for pharma marketers to know: Monday, June 4, 2018

By

New study finds early-stage breast cancer may not need chemo; Merck's Keytruda succeeds in more studies; Athenahealth CEO faces allegations of inappropriate behavior

AstraZeneca reprimanded by UK drug regulator for 'misleading' press release

AstraZeneca reprimanded by UK drug regulator for 'misleading' press release

By

A UK drug regulator has ruled that a 2017 press release from AstraZeneca was "misleading" as data "had not been presented in a balanced way", following a complaint from a fellow pharma firm.

How drugmakers are facing the entrance of consumer giants into healthcare

How drugmakers are facing the entrance of consumer giants into healthcare

By

As deepening healthcare forays by tech and e-commerce giants ratchet up the pressure on pharma to become more consumer friendly, drugmakers are still defining their new role.

Experts skeptical feds' move on Insys will tilt scales of justice against opioid maker

Experts skeptical feds' move on Insys will tilt scales of justice against opioid maker

Insys founder John Kapoor has maintained his innocence in the face of charges.

Alisa Lask, Galderma

Alisa Lask, Galderma

Alisa Lask is VP and GM, U.S. aesthetic business unit of Galderma, Nestlé Skin Health.

Elena Cant, Takeda

Elena Cant, Takeda

Elena Cant is VP, global head of vaccine commercial, Takeda Vaccine Business Unit of Takeda.

Meghan Rivera, Amag Pharmaceuticals

Meghan Rivera, Amag Pharmaceuticals

Meghan Rivera is VP, digital customer engagement of Amag Pharmaceuticals.

Wendy Blackburn, Intouch Solutions

Wendy Blackburn, Intouch Solutions

Wendy Blackburn is EVP, marketing and communications of Intouch Solutions.

Deborah Profit, Ostuka

Deborah Profit, Ostuka

Deborah Profit is VP, Otsuka Information Technology at Ostuka.

'Less about the product and more about the patient': Soundbites from Transforming Healthcare 2018

'Less about the product and more about the patient': Soundbites from Transforming Healthcare 2018

At MM&M's annual conference, panelists talked about how healthcare is moving toward value-based care and accelerating innovation

Former FDA commissioner Califf to pharma: opening up on health data requires overcoming risk

Former FDA commissioner Califf to pharma: opening up on health data requires overcoming risk

By

Califf spoke about the importance of more data to faster and cheaper drug development at the NewYorkBIO conference.

Whither the pharma Grand Prix? Questions abound in run-up to Cannes health fest

Whither the pharma Grand Prix? Questions abound in run-up to Cannes health fest

Whether jurors will award a pharma Grand Prix, and whether US pharma will show up, are two open questions in the run-up to Lions Health.

'Not a good day for Novartis': how the Novartis-Cohen crisis unfolded

'Not a good day for Novartis': how the Novartis-Cohen crisis unfolded

By

Here's a recap of the Novartis-Michael Cohen crisis, which unfolded this week, including how the drugmaker has responded to scrutiny over its $1.2 million contract with Cohen's firm.